Percutaneous cardiopulmonary support in refractory no-reflow with cardiogenic shock after coronary stenting in acute myocardial infarction

Jung Woo Son, Jin Sun Kim, Jung Myung Lee, Sung Jin Hong, Min Kyu Jung, Duk Hwan Kim, Jung Sun Kim, Donghoon Choi, Yangsoo Jang

Research output: Contribution to journalArticle

Abstract

Coronary no-reflow is defined as inadequate myocardial perfusion of a given coronary segment without angiographic evidence of mechanical vessel obstruction. No-reflow is visualized angiographically as a reduction in thrombolysis in myocardial infarction (TIMI) flow grade and is typically accompanied by chest pain, electrocardiographic changes with ST-segment shift and possible hemodynamic compromise. No-reflow during primary percutaneous coronary intervention (PCI) results in increasing mortality and morbidity. Therefore, treatment of noreflow is associated with improved clinical outcomes. Generally, the treatment of no-reflow is based on pharmacotherapy. In this case, despite maximal pharmacotherapy and intraaortic balloon pump (IABP), refractory no-reflow accompanied with cardiogenic shock was successfully treated with percutaneous cardiopulmonary support (PCPS).

Original languageEnglish
Pages (from-to)599-601
Number of pages3
JournalYonsei medical journal
Volume51
Issue number4
DOIs
Publication statusPublished - 2010 Jul

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Percutaneous cardiopulmonary support in refractory no-reflow with cardiogenic shock after coronary stenting in acute myocardial infarction'. Together they form a unique fingerprint.

  • Cite this